Nov 4, 2022, 11:16 by

Nov 4, 2022, 11:16 by

Nov 4, 2022, 11:15 by

medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials. Liege, Belgium - November 3, 2022: medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.

Nov 3, 2022, 11:17 by

Jumo Health, a global provider of age appropriate, culturally sensitive medical education resources, today announced it has been recognized by Inc. Magazine in its inaugural Power Partner Awards.

Nov 3, 2022, 01:00 by User Not Found

Clinical Research News | With the launch of Walmart Healthcare Research Institute earlier this month, the retail giant is doubling down on its efforts to be a healthcare destination for the masses. The aim is to make clinical research “equitable for all,” including people living in rural communities who have less access to trials than people in cities with an academic center nearby.

Nov 2, 2022, 10:32 by

Nov 2, 2022, 10:32 by

Nov 2, 2022, 10:31 by

BOC Sciences provides global customers with a range of high-quality stable isotope labeling compounds for biomedical research. It recently announced the availability of labeled carbohydrates, arousing an enthusiastic response from the market.

Nov 2, 2022, 10:31 by

BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is a significant contribution to the therapeutic areas.

Nov 2, 2022, 10:31 by

Owing to the continuously upgraded synthesis technologies and analytical abilities, BOC Sciences has performed well in the polymer industry, serving the community with a comprehensive product portfolio and valuable technical support.

Nov 2, 2022, 10:30 by

BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing comprehensive analysis and characterization technologies.

Nov 2, 2022, 10:29 by

Nov 2, 2022, 10:29 by

Nov 2, 2022, 10:29 by

Nov 2, 2022, 01:00 by User Not Found

Clinical Research News | Best practice surveillance protocols for seven diseases caused by group A Streptococcus (strep A) were recently released, and public health researchers are now actively working to identify several key sentinel sites to implement them. Harmonizing case definitions and the surveillance methodologies is a key step in accelerating development of a safe, effective, and affordable strep A vaccine to prevent these diseases.

Nov 1, 2022, 10:44 by

Nov 1, 2022, 10:43 by

Nov 1, 2022, 10:42 by

Nov 1, 2022, 10:41 by

Nov 1, 2022, 10:41 by